Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover the patented CN101817766A method for producing metanilic acid. Achieve 100% conversion with recyclable Pd/C catalysts, eliminating iron sludge and reducing costs for dye and pharma intermediates.
Patent CN112574285B reveals a novel solid-liquid phase synthesis for disulfide-bonded polypeptides, offering high purity and simplified manufacturing for pharmaceutical intermediates.
Patent CN118440041B details a novel seven-step synthesis for high purity chiral intermediates. This method ensures cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN114349754B details a high-yield ionic liquid method for 2,6-dichloropurine, offering pharmaceutical intermediate suppliers a greener, heavy-metal-free production route.
Advanced Pt/Bi catalytic hydrogenation technology for m-aminoacetophenone. Delivers superior selectivity, green processing, and reliable supply chain solutions for global pharmaceutical manufacturers.
Patent CN105566131B reveals Pt-Bi catalyst method for m-aminoacetophenone. High selectivity, green process, scalable supply chain solution for pharmaceutical intermediates.
Patent CN102234240B details a high-yield L-BMAA synthesis. Discover cost reduction in pharmaceutical intermediate manufacturing and scalable supply solutions.
Patent CN103408502A details a Bronsted acid-catalyzed, metal-free route to quinazolinones using O2. This method ensures high purity and significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN1197837C details a scalable Wittig-Horner route for C15 and C20 polyenoid units. Achieve cost reduction in fine chemical manufacturing via catalytic oxidation.
Patent CN1213998C details a novel route for antifolate intermediates using stable sulfonic acid salts, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Efficient fragment-based SPPS method for Nangibotide offering high purity and scalable manufacturing solutions for global pharmaceutical partners seeking reliable supply.
Advanced synthesis of Nifuratel avoiding hazardous reagents. Cost-effective pharmaceutical intermediates manufacturing with improved safety and scalability.
Patent CN114773316A details a scalable Grignard-based route for 2-(2,6-dioxo-piperidin-3-yl)-5-fluoro-isoindole-1,3-dione, offering high purity and cost-effective manufacturing for PROTAC intermediates.
Patent CN113683566A details a novel solvent-free synthesis of Edaravone achieving >99% purity. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN1098272C reveals a novel ether-silyl protection strategy for clarithromycin, offering high selectivity and cost reduction in antibiotic manufacturing for global supply chains.
Patent CN104086487B reveals ionic liquid method for caprolactam. Reduces waste and cost. Reliable supply chain solution for polymer and pharma intermediates.
Patent CN112795603B reveals a high-efficiency IRED method for chiral pyrrolidines, offering superior purity and green manufacturing advantages.
Patent CN103387556A details a safer synthetic route for alpha-acetyl-gamma-butyrolactone, eliminating hazardous reagents while achieving yields over 85%.
Patent CN116903499B reveals a novel anhydrous copper salt synthesis enabling cost reduction in pharmaceutical intermediate manufacturing and high-purity trifluoromethylation.
Advanced patent CN106045970A details high-yield Efinaconazole intermediate production with reduced impurities and scalable mild conditions for supply chain stability.